Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients

We divided patients in 2 groups. First group was the patients who received Oxiris filters during CRRT. Second group was the patiens who have received CRRT filters other than Oxiris.

We compared the lab parameters (Urea, Creatinin, Lactate, ABG parameters and SOFA escore with together.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis - to Reduce Mortality in the Intensive Care Unit Cytokine Hemodiafiltration

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bakirkoy Dr Sadi Konuk Research and Training Hospital

Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

sepsis diagnosis CRRT indication

Exclusion criteria

patients under age of 18

Treatment and study plan

CRRT

Other

Hemodiafiltration

Primary outcomes

SOFA Score

Time frame: 6 month

We compared SOFA scores of patients on admission and on 5th day.

Secondary outcomes

Survival comparison

Time frame: 6 month

We compared patients survival rates between two group.

Sponsors and collaborators

Lead sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Other Gov

Registry information

Official study title

Comparative Effectiveness of Oxiris Filters Versus Conventional Hemofilters in Septic Patients: a Retrospective Cohort Study

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Dec 16, 2024
Registry last updated: Dec 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed